Preferential inhibition of glioblastoma cells with wild-type epidermal growth factor receptors by a novel tyrosine kinase inhibitor ethyl-2,5-dihydroxycinnamate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples